Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Beyond Performance Status: Electronic Activity Monitoring to Assess Functional Activity of Patients With Gastrointestinal Malignancy During Chemotherapy.

Completed

Conditions: Gastrointestinal Cancer

Interventions: Device: Electronic Activity Monitoring (EAM)
Behavioral: Daily Questionnaire

First Posted Date: 2016-09-21

Last Posted Date: 2020-08-25

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 54

Registration Number: NCT02909062

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Memorial Sloan Kettering Rockville Centre, Rockville Centre, New York, United States
🇺🇸
Memorial Sloan Kettering Commack, Commack, New York, United States

and more 2 locations

A Study to Assess Thymic Function Using PET/CT and MRI

Completed

Conditions: CD34 Selected Peripheral Blood Stem Cell Graft

Interventions: Device: PET/CT scans
Device: MRI

First Posted Date: 2016-09-21

Last Posted Date: 2020-01-27

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 3

Registration Number: NCT02909075

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Memorial Sloan-Kettering Cancer Center at Commack, Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Westchester, Harrison, New York, United States

A Study to Determine if Mesh Placement During Bladder Surgery Can Reduce the Chances of Developing a Hernia

Phase 3

Active, not recruiting

Conditions: Radical Cystectomy

Interventions: Procedure: Surgery Radical Cystectomy
Procedure: Ultrapro mesh

First Posted Date: 2016-09-20

Last Posted Date: 2024-04-25

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 178

Registration Number: NCT02908061

Locations: 🇺🇸
Memorial Sloan Kettering Commack (Consent and follow-up only), Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge (Consent and follow-up only), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Westchester (Consent and follow-up only), Harrison, New York, United States

and more 4 locations

Intraoperative Radiation Therapy for Locally Advanced or Recurrent Abdomino-pelvic Solid Tumors With the CivaSheet

Phase 1

Completed

Conditions: Abdominal Malignancy
Pelvic Malignancy

Interventions: Device: CivaSheet
Radiation: Brachytherapy
Procedure: surgical resection

First Posted Date: 2016-09-15

Last Posted Date: 2024-10-21

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 14

Registration Number: NCT02902107

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

A Risk Assessment Tool to Increase Statin Use Among High Risk Cancer Survivors: Development and Pilot Testing

Completed

Conditions: Statin Use Among High Risk Survivors
Cancer Survivors

Interventions: Behavioral: statin communication tool
Behavioral: usual care

First Posted Date: 2016-09-12

Last Posted Date: 2020-06-16

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 49

Registration Number: NCT02895880

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Haploidentical (Half-matched) Related Donor Stem Cell Transplantation Using Killer Immunoglobulin-like Receptors in Addition to Normal Selection Factors to Determine the Best Donor

Not Applicable

Completed

Conditions: Hematologic Malignancy

Interventions: Drug: melphalan
Drug: fludarabine
Drug: thiotepa
Drug: Cyclophosphamide
Drug: Mesna
Drug: Mycophenolate Mofetil
Drug: Filgrastim
Drug: Tacrolimus

First Posted Date: 2016-08-26

Last Posted Date: 2024-12-06

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 44

Registration Number: NCT02880293

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Assessing 11C-Choline (11C-CH) PET to Distinguish True Tumor Progression From Pseudoprogression in High-grade Gliomas

Not Applicable

Completed

Conditions: Brain Cancer

Interventions: Device: PET scan
Radiation: C-Choline

First Posted Date: 2016-07-29

Last Posted Date: 2022-12-29

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 8

Registration Number: NCT02849171

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Study of Abemaciclib in Dedifferentiated Liposarcoma

Phase 2

Active, not recruiting

Conditions: Dedifferentiated Liposarcoma
Sarcoma

Interventions: Drug: Abemaciclib

First Posted Date: 2016-07-27

Last Posted Date: 2025-06-05

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 33

Registration Number: NCT02846987

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

The Patient-Perspective of Complications After Colon and Rectum Surgery: A Qualitative Analysis

Completed

Conditions: Colorectal Cancer

Interventions: Behavioral: qualitative interviews

First Posted Date: 2016-07-19

Last Posted Date: 2017-06-29

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 9

Registration Number: NCT02836535

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Validation of a Health-Related Symptom Index for Persons Diagnosed With and Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions (HSIL)

Completed

Conditions: Anal High-Grade Squamous Intraepithelial Lesions

First Posted Date: 2016-07-19

Last Posted Date: 2023-09-01

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 406

Registration Number: NCT02836522

Locations: 🇺🇸
Memorial Sloan - Kettering Cancer Center, New York, New York, United States
🇺🇸
City College of New York, New York, New York, United States
🇺🇸
New York Presbyterian Hospital-Weill Medical College of Cornell University, New York, New York, United States

and more 1 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy